Interestingly, the expression of oncogenic HRAS or KRAS has been shown to induce tumor formation in vivo in a doxycycline-dependent manner, and withdrawal of the drug resulted in tumor shrinkage [21, 22]. The gene discussed is KRAS; the disease is neoplasm.